Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function.
Quercioli A, Carbone F, Bonaventura A, Liberale L, Pataky Z, Thomas A, Lenglet S, Lauer E, Golay A, Dallegri F, Di Marzo V, Schindler TH, Montecucco F.
Quercioli A, et al. Among authors: pataky z.
Int J Cardiol. 2017 Mar 15;231:1-5. doi: 10.1016/j.ijcard.2016.12.023. Epub 2016 Dec 13.
Int J Cardiol. 2017.
PMID: 27989579